Penfluridol suppresses MYC-driven ANLN expression and liver cancer progression by disrupting the KEAP1-NRF2 interaction.
Nguyen MT, Lee GJ, Kim B, Kim HJ, Tak J, Park MK, Kim EJ, Kang GJ, Rho SB, Lee H, Lee K, Kim SG, Lee CH.
Nguyen MT, et al. Among authors: kim hj, kim b, kim sg, kim ej.
Pharmacol Res. 2024 Dec;210:107512. doi: 10.1016/j.phrs.2024.107512. Epub 2024 Dec 4.
Pharmacol Res. 2024.
PMID: 39643070
Free article.